eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Johnson and Johnson Pharmaceutical Research and Development, LLC - Comment

Johnson and Johnson Pharmaceutical Research and Development, LLC - Comment

Document ID: FDA-2011-D-0436-0006
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: August 30 2011, at 12:00 AM Eastern Daylight Time
Date Posted: September 7 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: June 29 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: September 1 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f091c5
View Document:  View as format xml

View Comment

See attached comments by Line Number. For ease of international compilation we have noted Line Numbers from FDA and EMA versions of Q11.

Attachments:

Johnson and Johnson Pharmaceutical Research and Development, LLC - Comment

Title:
Johnson and Johnson Pharmaceutical Research and Development, LLC - Comment

View Attachment: View as format msw12 View as format pdf

Related Comments

    View All
Total: 23
AstraZeneca - Comment
Public Submission    Posted: 09/07/2011     ID: FDA-2011-D-0436-0004

Sep 01,2011 11:59 PM ET
MedImmune - Comment
Public Submission    Posted: 09/07/2011     ID: FDA-2011-D-0436-0005

Sep 01,2011 11:59 PM ET
Johnson and Johnson Pharmaceutical Research and Development, LLC - Comment
Public Submission    Posted: 09/07/2011     ID: FDA-2011-D-0436-0006

Sep 01,2011 11:59 PM ET
Pfizer Inc. - Comment
Public Submission    Posted: 09/07/2011     ID: FDA-2011-D-0436-0007

Sep 01,2011 11:59 PM ET
Shire Pharmaceuticals Inc. - Comment
Public Submission    Posted: 09/07/2011     ID: FDA-2011-D-0436-0008

Sep 01,2011 11:59 PM ET